Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.63 |
| ▸ | CTSA | P10619 | 1/20 | 0.49 |
| ▸ | RORB | Q92753 | 2/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.47 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.47 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | IKBKB | O14920 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RORC | P51449 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27926363 | 0.86 | BCAT2 (0.76) | BCAT2KEAP1NFE2L2CHEK1CASP1 | |
| SCHEMBL3632126 | 0.86 | BCAT2 (0.65) | BCAT2RORBCHEK1CASP1IKBKB | |
| SCHEMBL411720 | 0.83 | HNF4A (0.52) | BCAT2RORBKDM4EALDH1A1MAPT | |
| SCHEMBL197002 | 0.83 | BCAT2 (0.71) | BCAT2CHEK1CASP1IKBKBKDM4E | |
| SCHEMBL28270443 | 0.81 | BCAT2 (0.69) | BCAT2CHEK1CASP1IKBKBKDM4E | |
| SCHEMBL27843687 | 0.81 | BCAT2 (0.81) | BCAT2KEAP1NFE2L2CHEK1CASP1 | |
| SCHEMBL5878337 | 0.80 | BCAT2 (0.87) | BCAT2KEAP1NFE2L2CHEK1IKBKB | |
| SCHEMBL3234101 | 0.79 | BCAT2 (0.59) | BCAT2RORBPDK2CHEK1CASP1 | |
| SCHEMBL10908563 | 0.79 | BCAT2 (0.77) | BCAT2CTSAKEAP1NFE2L2CHEK1 | |
| SCHEMBL5273765 | 0.78 | CASP1 (0.59) | BCAT2PDK2CHEK1CASP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090011935-A1 | Method of Inducing Tolerance of Plants Against Bacterioses | BASF SE (DE) | 2009-01-08 | — | — | US | claimed |
| EP-1996018-A2 | METHOD OF INDUCING TOLERANCE OF PLANTS AGAINST BACTERIOSES | BASF SE (DE) | 2008-12-03 | — | — | EP | claimed |
| WO-2007104658-A2 | METHOD OF INDUCING TOLERANCE OF PLANTS AGAINST BACTERIOSES | BASF SE (DE) | 2007-09-20 | — | — | WO | claimed |
| EP-2259675-B1 | FUNGICIDAL COMPOSITIONS COMPRISING 3'-BROMINE-2,3,4,6'-TETRAMETHOXY-2'-6-DIMETHYLBENZOPHENONE | BASF SE (DE) | 2015-10-07 | — | — | EP | disclosed |
| EP-2392662-A2 | Plant produtivity enhancement by combining chemical agents with transgenic modifications | BASF SE (DE) | 2011-12-07 | — | — | EP | disclosed |
| EP-2259675-A2 | FUNGICIDAL COMPOSITIONS COMPRISING 3'-BROMINE-2,3,4,6'-TETRAMETHOXY-2'-6-DIMETHYLBENZOPHENONE | BASF SE (DE) | 2010-12-15 | — | — | EP | disclosed |
| US-20100093715-A1 | Plant productivity enhancement by combining chemical agents with transgenic modifications | BASF SE (DE) | 2010-04-15 | — | — | US | disclosed |
| WO-2010015634-A1 | METHOD FOR SCREENING FOR A PLANT PROTECTANT | BASF SE (DE) | 2010-02-11 | — | — | WO | disclosed |
| EP-2150106-A2 | ACTIVE INGREDIENT COMPOSITIONS FOR PLANT PROTECTION | BASF SE (DE) | 2010-02-10 | — | — | EP | disclosed |
| WO-2010010005-A2 | OIL-IN-WATER EMULSION COMPRISING SOLVENT, WATER, SURFACTANT AND PESTICIDE | BASF SE (DE) | 2010-01-28 | — | — | WO | disclosed |
| EP-2142293-A2 | ENZYMATIC METHOD FOR THE PRODUCTION OF MICROCAPSULES | BASF SE (DE) | 2010-01-13 | — | — | EP | disclosed |
| EP-2076602-A2 | PLANT PRODUTIVITY ENHANCEMENT BY COMBINING CHEMICAL AGENTS WITH TRANSGENIC MODIFICATIONS | BASF SE (DE) | 2009-07-08 | — | — | EP | disclosed |
| US-20090011935-A1 | Method of Inducing Tolerance of Plants Against Bacterioses | BASF SE (DE) | 2009-01-08 | — | — | US | disclosed |
| EP-1996018-A2 | METHOD OF INDUCING TOLERANCE OF PLANTS AGAINST BACTERIOSES | BASF SE (DE) | 2008-12-03 | — | — | EP | disclosed |
| WO-2008132179-A2 | ACTIVE INGREDIENT COMPOSITIONS FOR PLANT PROTECTION | BASF SE (DE) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008132067-A2 | ENZYMATIC METHOD FOR THE PRODUCTION OF MICROCAPSULES | BASF SE (DE) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008129060-A2 | PLANT PRODUTIVITY ENHANCEMENT BY COMBINING CHEMICAL AGENTS WITH TRANSGENIC MODIFICATIONS | BASF SE (DE) | 2008-10-30 | — | — | WO | disclosed |
| WO-2007104658-A2 | METHOD OF INDUCING TOLERANCE OF PLANTS AGAINST BACTERIOSES | BASF SE (DE) | 2007-09-20 | — | — | WO | disclosed |
| EP-1453828-A2 | AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME | AstraZeneca AB (SE) | 2004-09-08 | — | — | EP | disclosed |
| WO-2003032897-A2 | AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME | ASTRAZENECA AB (SE) | 2003-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090011935-A1 | Method of Inducing Tolerance of Plants Against Bacterioses | BROX, CAT, SLC11A2 | BCAT2 142/4885CTSA 1543/4885RORB 1856/4885 |
| US-20100093715-A1 | Plant productivity enhancement by combining chemical agents with transgenic modifications | CBR3, MYB, HACL2 | BCAT2 716/4885CTSA 4206/4885RORB 2782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.